Ver Publicación - Prisma - Unidad de Bibliometría

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Morrison, C ; Pabla, S; Conroy, JM; Nesline, MK; Glenn, ST; Dressman, D; Papanicolau-Sengos, A; Burgher, B; Andreas, J; Giamo, V; Qin, MC; Wang, YR; Lenzo, FL; Omilian, A; Bshara, W; Zibelman, M; Ghatalia, P; Dragnev, K; Shirai, K; Madden, KG; Tafe, LJ; Shah, N; Kasuganti, D; de la Cruz-Merino, L; Araujo, I; Saenger, Y; Bogardus, M; Villalona-Calero, M; Diaz, Z; Day, R; Eisenberg, M; Anderson, SM; Puzanov, I; Galluzzi, L; Gardner, M; Ernstoff, MS

Tipo: Artículo
Año de Publicación: 2018
Volumen: 6
Número: 1
Número de artículo: 32
Acceso abierto: Vía dorada
Fuente Nº Citas Fecha Actualización
scopus11321-12-2024
wos11022-12-2024
Dimensions
PlumX
Altmetric

Año: 2018

Journal Impact Factor (JIF): 8.7280

CategoríaEdiciónPosiciónCuartilTercilDecil
IMMUNOLOGYSCIE12/158Q1T1D1
ONCOLOGYSCIE19/230Q1T1D1

Año: 2018

Journal Citation Indicator (JCI): 1,700

CategoríaPosiciónCuartilTercilDecilPercentil
IMMUNOLOGY16/175Q1T1D191,14
ONCOLOGY22/302Q1T1D192,88

Año:

2018

CiteScore:

9,000

CategoríaPosiciónCuartilTercilDecil
Pharmacology16/301Q1T1D1
Cancer Research32/194Q1T1D2
Immunology31/198Q1T1D2
Immunology and Allergy27/186Q1T1D2
Molecular Medicine19/167Q1T1D2
Oncology38/323Q1T1D2

SJR año:

2018

Factor de Impacto:

3,337

CategoríaPosiciónCuartilTercilDecil
Cancer Research16/241Q1T1D1
Immunology19/228Q1T1D1
Immunology and Allergy15/217Q1T1D1
Molecular Medicine7/179Q1T1D1
Oncology20/401Q1T1D1
Pharmacology7/343Q1T1D1
No existen datos para la revista de esta publicación.
Agencia Código de Proyecto
OmniSeq, Inc. (Buffalo, NY)-
Nota: los datos sobre financiación provienen de la WOS
# Autor Afiliación
1Morrison, C Roswell Park Cancer Institute; OmniSeq Inc. (United States)
2Pabla, SOmniSeq Inc. (United States)
3Conroy, JMRoswell Park Cancer Institute; OmniSeq Inc. (United States)
4Nesline, MKOmniSeq Inc. (United States)
5Glenn, STRoswell Park Cancer Institute; OmniSeq Inc. (United States)
6Dressman, DOmniSeq Inc. (United States)
7Papanicolau-Sengos, AOmniSeq Inc. (United States)
8Burgher, BOmniSeq Inc. (United States)
9Andreas, JOmniSeq Inc. (United States)
10Giamo, VOmniSeq Inc. (United States)
11Qin, MCOmniSeq Inc. (United States)
12Wang, YROmniSeq Inc. (United States)
13Lenzo, FLOmniSeq Inc. (United States)
14Omilian, ARoswell Park Cancer Institute (United States)
15Bshara, WRoswell Park Cancer Institute (United States)
16Zibelman, MFox Chase Cancer Center (United States)
17Ghatalia, PFox Chase Cancer Center (United States)
18Dragnev, KSin datos ()
19Shirai, KSin datos ()
20Madden, KGSin datos ()
21Tafe, LJSin datos ()
22Shah, NCommunity Hospital (United States)
23Kasuganti, DCommunity Hospital (United States)
24de la Cruz-Merino, LHospital Universitario Virgen Macarena (Spain)
25Araujo, IHospital Universitario Virgen Macarena (Spain)
26Saenger, YColumbia University in the City of New York (United States)
27Bogardus, MColumbia University in the City of New York (United States)
28Villalona-Calero, MBaptist Health South Florida (United States)
29Diaz, ZBaptist Health South Florida (United States)
30Day, RUniversity of Pittsburgh (United States)
31Eisenberg, MLaboratory Corporation of America Holdings (United States)
32Anderson, SMLaboratory Corporation of America Holdings (United States)
33Puzanov, IRoswell Park Cancer Institute (United States)
34Galluzzi, LUniversité de Paris; Weill Cornell Medicine (United States)
35Gardner, MOmniSeq Inc. (United States)
36Ernstoff, MSRoswell Park Cancer Institute (United States)